Best practices for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis

World J Gastrointest Endosc. 2021 Jun 16;13(6):161-169. doi: 10.4253/wjge.v13.i6.161.

Abstract

Acute pancreatitis is of one the most common gastroenterology-related indications for hospital admissions worldwide. With the widespread reliance on endoscopic retrograde cholangiopancreatography (ERCP) for the management of pancreaticobiliary conditions, post-ERCP pancreatitis (PEP) has come to represent an important etiology of acute pancreatitis. Despite many studies aiming to better understand the pathogenesis and prevention of this iatrogenic disorder, findings have been heterogeneous, and considerable variation in clinical practice exists. Herein, we review the literature regarding PEP with the goal to raise awareness of this entity, discuss recent data, and present evidence-based best practices. We believe this manuscript will be useful for gastrointestinal endoscopists as well as other specialists involved in the management of patients with PEP.

Keywords: Endoscopic retrograde cholangiopancreatography; Pancreatitis; Pharmacology; Post-endoscopic retrograde cholangiopancreatography pancreatitis; Practice guidelines; Prevention.

Publication types

  • Review